trending Market Intelligence /marketintelligence/en/news-insights/trending/8r817SBkEjhfTe9Dfnafpw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Humana acquiring hospice pharmacy, benefit management provider Enclara

Infrastructure Issues: Tools to Dig Deep on Potential Risks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools


Humana acquiring hospice pharmacy, benefit management provider Enclara

Humana Inc. agreed to acquire privately held hospice pharmacy and benefit management provider Enclara Healthcare from Consonance Capital Partners and Enclara management.

The transaction includes the acquisition of Enclara Pharmacia, GuidantRx and Avanti Health Care Services. Financial terms of the transaction were not disclosed, and certain assets are excluded.

The transaction is expected to have an immaterial impact to Humana's earnings in 2020. It is anticipated to close during the first half of 2020 and is subject to customary state and federal regulatory approvals as well as other customary closing conditions.

Enclara serves over 450 hospice providers and 97,000 hospice patients per day.

Centerview Partners LLC is serving as financial adviser to Humana. Crowell & Moring LLP is acting as legal adviser to Humana. Evercore Inc. is acting as financial adviser to Enclara and Consonance Capital. Latham & Watkins LLP is acting as legal adviser to Enclara and Consonance Capital.